MedPage Today on MSN
Study: Helping Lupus Patients With Money Issues Improves Their Health
It's long been known that money woes tend to worsen health outcomes in people with chronic diseases. The demographics of ...
In a new study, researchers examined herbal supplements with immune-activating properties that could trigger or worsen ...
It's more important than ever before for your elected officials to hear from you - don't miss your chance to turn Capitol ...
Defense spending bill includes restoration of millions in lupus research funding that had been eliminated last year ...
Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...
Flow Space on MSN
The silent burden of lupus flares: How to advocate for yourself when symptoms don't add up
Lupus is often marked by flares, which is when symptoms are usually more obvious.
1don MSN
AstraZeneca’s subcutaneous Saphnelo shows significant disease reduction in landmark lupus trial
AstraZeneca (NASDAQ:AZN) is one of the best future stocks to buy for the long term. On January 6, Barclays analyst James ...
Higher levels of antimitochondrial antibodies in patients with systemic lupus erythematosus are tied to a higher risk for ...
Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy ...
GSK plc (LSE/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly ...
— -- Selena Gomez is finally opening up about the real reason she took some time off in 2013: The pop star was busy with treatment for lupus. In a new interview with Billboard, the actress-singer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results